⟵ Back to Search Results
BGB-283/PD-0325901-AU-001

Recruiting

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

Beigene Study ID info

BGB-283/PD-0325901-AU-001

ClinicalTrials.gov ID info

NCT03905148

Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 56

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 78

Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 84

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 323

Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 329

No Study Documents